Some cancers found earlier after Medicaid expansion
Low-income patients were less likely to be diagnosed with advanced screening-detected...Read more on AuntMinnie.comRelated Reading: Medicaid expansion tied to early breast cancer diagnosis Medicaid expansion under ACA linked to fewer cancer deaths Poor, rural women less likely to get breast cancer screening CT lung screening rates show gradual upward trend Insurance plays major role in breast cancer disparities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2020 Category: Radiology Source Type: news

Study Supports Changing Classification of Renal Cell Carcinoma Study Supports Changing Classification of Renal Cell Carcinoma
The definition of stage 4 renal cell carcinoma should be expanded to include lymph node-positive stage 3 disease, according to a new study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 7, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Wcgc 2020 wcgc 2020
Read clinically focused news coverage of key developments from WCGC 2020Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2020 Category: Consumer Health News Tags: Conference Coverage Source Type: news

HiberCell Announces Acquisition of Biothera Pharmaceuticals' Imprime PGG Program
Imprime PGG, a novel immune activator, has undergone rigorous Phase II testing for the treatment of metastatic breast cancer Biothera president and chief scientific officer, Jeremy R. Graff, Ph.D., will assume the role of chief development officer at Hi... Biopharmaceuticals, Oncology, Acquisitions HiberCell, Biothera Pharmaceuticals, Imprime PGG, disseminated tumor cells (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2020 Category: Pharmaceuticals Source Type: news

Early Breast Cancer Screening Benefits Childhood Cancer Survivors
Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 7, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Radiology, Journal, Source Type: news

Lifestyle Choices May Reduce Breast Cancer Risk Regardless of Genetics Lifestyle Choices May Reduce Breast Cancer Risk Regardless of Genetics
Women, regardless of genetic risk, may be able to reduce their risk of breast cancer through lifestyle changes, a large study of more than 90,000 women suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

GPs report rise in cancer referrals rejected unfairly during COVID-19 pandemic
One in four UK GPs say rising numbers of cancer referrals have been rejected inappropriately during the COVID-19 pandemic, amid concerns that thousands of cases of cancer may have been missed. (Source: GP Online News)
Source: GP Online News - July 7, 2020 Category: Primary Care Tags: Coronavirus Source Type: news

Health panel may open lung cancer screening to more smokers
A U.S. health panel wants to widen the number of current and former smokers offered yearly scans for lung cancer (Source: ABC News: Health)
Source: ABC News: Health - July 7, 2020 Category: Consumer Health News Tags: Health Source Type: news

Rise in Talc Cases Reshapes Traditional Asbestos Litigation
A recent rise in litigation linking cosmetic talc with mesothelioma and lung cancer will continue throughout 2020, despite companies abandoning the product in the hope of avoiding costly verdicts. The number of legal cases is expected to increase by 10% this year, building on an 11% rise in 2019, according to KCIC, a well-regarded consulting firm based in Washington, D.C., that manages asbestos product liabilities. “A new trend we have started to see is talc allegations showing up in traditional asbestos complaints,” said KCIC Vice President Michelle Potter during a recent webinar that looked at past litigation...
Source: Asbestos and Mesothelioma News - July 7, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Radiomics Can Identify High-Risk Early Stage Lung Cancer Radiomics Can Identify High-Risk Early Stage Lung Cancer
Radiomics can improve lung cancer screening by identifying patients with early stage lung cancer at high risk for poorer outcomes who could benefit from aggressive therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Early Screening May Curb Breast Cancer Deaths in Childhood Cancer Survivors Early Screening May Curb Breast Cancer Deaths in Childhood Cancer Survivors
In childhood cancer survivors, starting annual magnetic resonance imaging (MRI) screening at ages 25-30 may reduce breast cancer deaths by at least 50%, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 7, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

What patients need right now
  Lockdown is a “prison like” experience, for Londoner Annabelle Ume, who suffers from myalgic encephalomyelitis. “It’s very similar to being trapped in a bunker with no access outside,” says Ume.   Many other fellow sufferers are enduring pandemic enforced isolation without much hope. “They are staying in limbo until help is available and adapting to the worsening of their health conditions,” says Ume. “You just try to make mental peace with it because the physical can’t be addressed at this time.” COPD sufferer John Linnell from Wisconsin i...
Source: EyeForPharma - July 7, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Renowned NCI-designated cancer center becomes the 38th member of Caris Life Sciences' collaborative network focused on research and the application of precision medicine in oncology IRVING, Texas, July 7, 2020 -- (Healthcare Sales & Marketing Network) ... Diagnostics, Oncology Caris Life Sciences, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2020 Category: Pharmaceuticals Source Type: news

Popular Heartburn Drugs Linked to Heightened COVID-19 Risk
A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus. In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Entrectinib Results Emphasize Need for NTRK Detection Entrectinib Results Emphasize Need for NTRK Detection
Although NTRK fusion genes are rare in gastrointestinal cancers, they should be looked for, inasmuch as responses to the TRK inhibitor entrectinib are robust and durable, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
TUESDAY, July 7, 2020 -- The U.S. Preventive Services Task Force (USPSTF) recommends annual low-dose computed tomography (LDCT) screening for people aged 50 to 80 years at high lung cancer risk due to smoking history. These recommendations form the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2020 Category: Pharmaceuticals Source Type: news

Early Breast Cancer Screening Benefits Childhood Cancer Survivors
TUESDAY, July 7, 2020 -- For childhood cancer survivors, early initiation of breast cancer screening with magnetic resonance imaging (MRI) may reduce breast cancer mortality by more than half, according to a study published online July 7 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2020 Category: Pharmaceuticals Source Type: news

New Guidelines Could Double Number Eligible for Lung Cancer Screening
TUESDAY, July 7, 2020 -- CT scans have been proven to help spot lung cancer early and save lives. Now, updated expert recommendations could double the number of Americans who are eligible for the yearly screening. The recommendations -- from the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 7, 2020 Category: General Medicine Source Type: news

Antihypertensives Reduce Risk of Colorectal Cancer
Antihypertensives Linked to Reduced Risk of Colorectal Cancer (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 7, 2020 Category: General Medicine Source Type: news

What Is a Bronchovascular Sleeve Resection?
Title: What Is a Bronchovascular Sleeve Resection?Category: Procedures and TestsCreated: 7/7/2020 12:00:00 AMLast Editorial Review: 7/7/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 7, 2020 Category: Cancer & Oncology Source Type: news

Breast Cancer Caught Earlier in U.S. States With Expanded Medicaid: Study
Title: Breast Cancer Caught Earlier in U.S. States With Expanded Medicaid: StudyCategory: Health NewsCreated: 7/6/2020 12:00:00 AMLast Editorial Review: 7/7/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 7, 2020 Category: Cancer & Oncology Source Type: news

Obamacare Helps Poorer Americans Spot Cancer Earlier: Study
Title: Obamacare Helps Poorer Americans Spot Cancer Earlier: StudyCategory: Health NewsCreated: 7/6/2020 12:00:00 AMLast Editorial Review: 7/7/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 7, 2020 Category: Cancer & Oncology Source Type: news

Common Blood Pressure Meds May Lower Colon Cancer Risk
Title: Common Blood Pressure Meds May Lower Colon Cancer RiskCategory: Health NewsCreated: 7/6/2020 12:00:00 AMLast Editorial Review: 7/7/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 7, 2020 Category: Cancer & Oncology Source Type: news

MIM Software launches practice improvement tool
Medical imaging software developer MIM Software has launched MIM Harmony, a...Read more on AuntMinnie.comRelated Reading: DocPanel picks MIM software MIM Software, Sitex team up to treat cancer IsoRay, MIM Software team on treatment for head, neck cancer MIM Software adds to customer list Philips, MIM to collaborate on radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2020 Category: Radiology Source Type: news

Can radiomics improve CT lung cancer screening?
Two radiomics features on low-dose CT (LDCT) exams in lung cancer screening...Read more on AuntMinnie.comRelated Reading: AI improves interpretation of CT lung cancer images Muscle metrics on chest CT can predict mortality risk AI can predict if COVID-19 patients will need ventilators CT radiomics unlocks basal ganglia stroke onset time CT radiomics predicts lung cancer immunotherapy response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2020 Category: Radiology Source Type: news

Earlier breast screening benefits women with childhood cancer
Women who had cancer in childhood treated with chest radiotherapy may strongly...Read more on AuntMinnie.comRelated Reading: How mammography screening succeeded in Sweden Interval breast cancers have unique characteristics Breast screening interventions are cost-effective Would ultrasound work for primary breast screening? Breast MRI's better cancer detection outweighs false-positive 'harm' (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2020 Category: Radiology Source Type: news

Request for Information (RFI): Seeking Stakeholder Input on Scientific Gaps and Research Needs Related to Delivery of Cancer-related Care via Telehealth
The National Cancer Institute (NCI) is seeking input on scientific gaps and research needs that should be addressed as cancer-related care via telehealth becomes a more common part of routine clinical practice. This RFI is part of a planning effort to identify promising research opportunities, methods, and strategies to address gaps in this area. Responses are accepted through July 30, 2020. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - July 7, 2020 Category: Rural Health Source Type: news

Host cell fusion in bacteria infection alarms immune system, causing host cell destruction
(National University of Singapore, Yong Loo Lin School of Medicine) NUS Medicine researchers have identified a new trigger for our immune system--abnormal fusion of host cells to form giant cells after infection by pathogens such as the bacterium Burkholderia pseudomallei. Cell fusion triggered the cGAS-STING pathway, activating a type 1 interferon response which kills pathogens. In extensive cell fusion, cGAS-STING caused the giant cells to self-destruct instead. Since the DNA in the giant cells was damaged, self-destruction likely prevents these cells from becoming cancerous. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

JNCCN study explores if insurance is keeping pace with trends in targeted cancer therapy
(National Comprehensive Cancer Network) New research from the University of California, San Francisco (USCF) and City of Hope in the July 2020 issue of JNCCN--Journal of the National Comprehensive Cancer Network examines coverage trends for circulating tumor DNA testing, also known as gene sequencing of ctDNA or 'liquid biopsies.' The researchers found coverage rate rose from 0% to 38% in three years. The policies also increased in scope from 2017-2019, going from one cancer type to 12. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Addressing the toxicity of cancer treatment costs
(Wayne State University - Office of the Vice President for Research) Financial toxicity affects an estimated 30% to 50% of patients with cancer, especially patients who are racial/ethnic minorities, have lower incomes or are under 65. However, well-timed and effective patient-oncologist treatment cost discussions could help.A team from Wayne State University are working to improve patient-provider discussions on costs of cancer treatment with the help of a grant from the American Cancer Society. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 7, 2020 Category: International Medicine & Public Health Source Type: news

Blocking cholesterol storage could stop growth of pancreatic tumors
(Cold Spring Harbor Laboratory) Scientists at Cold Spring Harbor Laboratory found they can stop the growth of pancreatic cancer cells by interfering with the way the cells store cholesterol. Their findings in mice and lab-grown pancreas models point toward a new strategy for treating deadly pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Protein linked to cancer acts as a viscous glue in cell division
(Rensselaer Polytechnic Institute) The protein PRC1, a telltale sign in many cancer types including prostate, ovarian, and breast cancer, act as a " viscous glue " during cell division, precisely controlling the speed at which two sets of DNA are separated as a single cell divides. The finding could explain why too much or too little PRC1 disrupts that process and causes genome errors linked to cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

A key gene modifies regulatory T cells to fine-tune the immune response
(Salk Institute) The human immune system is a finely-tuned machine, balancing when to release a cellular army to deal with pathogens, with when to rein in that army, stopping an onslaught from attacking the body itself. Now, Salk researchers have discovered a way to control regulatory T cells, immune cells that act as a cease-fire signal, telling the immune system when to stand down. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

The study of lysosomal function during cell division and chromosomal instability
(IDIBELL-Bellvitge Biomedical Research Institute) By studying the role of lysosomes in mitosis, an IDIBELL and UB group discovers that alterations in the separation of chromosomes cause a detectable nucleus morphology once mitosis has finished.This morphology would be useful to identify cells that have chromosomal instability inherent in cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Engineered killer immune cells target tumours and their immunosuppressive allies
(eLife) Scientists have engineered natural killer immune cells that not only kill head and neck tumour cells in mice but also reduce the immune-suppressing myeloid cells that allow tumours to evade the immune response, according to a new study in eLife. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Study: Surgical delay associated with increased risk in some gastrointestinal malignancies
(Beth Israel Deaconess Medical Center) Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or " non-emergency " operations were implemented to free up hospital beds and conserve protective equipment for health care workers. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center examined the effects of delaying surgery for gastrointestinal cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Diagnosis to therapy: The future of image-guided patient management
(Society of Nuclear Medicine and Molecular Imaging) SNMMI's Virtual Annual Meeting will convene more than 6,000 attendees from around the globe to share novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more.The focus is on precision medicine--improving patients' lives by developing new ways to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient's disease, and monitoring and adjusting treatment to ensure optimum results. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

RNA key in helping stem cells know what to become
(University of Colorado at Boulder) If every cell has the same genetic blueprint, why does an eye cell look and act so differently than a brain cell or skin cell? In a new study published this week, researchers come one step closer to solving this mystery, showing RNA plays a critical role. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

A 3D biofabricated cutaneous squamous cell carcinoma tissue model
(Impact Journals LLC) The cover for issue 27 of Oncotarget features Figure 4, " (A) Bimodal imaging examples of control and treated tumors (red) before and after the treatment period, " by Browning, et al. and reported that the authors developed a 3-dimensional bioprinted skin model of cutaneous squamous cell carcinoma (cSCC) tumors together with a microscopy assay to test chemotherapeutic effects in tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Oncotarget: Epigenetic feedback and stochastic partitioning can drive resistance to EMT
(Impact Journals LLC) Oncotarget Volume 11, Issue 27 published " Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT " by Jia et al. which reported that Epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial transition are central to metastatic aggressiveness and therapy resistance in solid tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

BIO Integration Journal, volume 1, issue number 1, publishes
(Compuscript Ltd) New journal BIO Integration (BIOI) has been launched with the publication of volume 1, issue 1. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Oncotarget: Australian experience of peptide receptor radionuclide therapy
(Impact Journals LLC) Oncotarget Volume 11, Issue 27 published " Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours " by Lim et al. which reported peptide receptor radionuclide therapy (PRRT) is an approved treatment modality for gastroenteropancreatic neuroendocrine tumours, although Phase III randomised clinical trial data is not available for NETs of other site of origin, in practice, PRRT is used more widely in clinical practice, based on its mechanism of targeting the somatostatin receptor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Oncotarget: Clonality and antigen-specific responses shape prognostic effects
(Impact Journals LLC) Oncotarget Volume 11, Issue 27 reported that to delineate the complexity of anti-tumor T-cell responses, the author's utilized a computational method for de novo assembly of sequences from CDR3 regions of 369 high-grade serous ovarian cancers from TCGA, and then applied deep TCR-sequencing for analyses of paired tumor and peripheral blood specimens from an independent cohort of 99 ovarian cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Oncotarget: Correction of NSE concentration improves diagnostic accuracy in lung cancer
(Impact Journals LLC) Oncotarget Volume 11, Issue 27 published " Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer " by Genet et al. which reported that this study aimed to develop a hemolysis correction equation and evaluate its role in small-cell lung cancer (SCLC) diagnostics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

Custom nanoparticle regresses tumors when exposed to light
(Penn State) A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to a team of Penn State researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2020 Category: Cancer & Oncology Source Type: news

CRC With Peritoneal Metastases: CRS-HIPEC Refinements CRC With Peritoneal Metastases: CRS-HIPEC Refinements
Refinements to the treatment pathway may improve overall survival in patients with colorectal cancer who have peritoneal metastases, suggest four new studies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 7, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

As it seeks prostate cancer drug approval, Peninsula drug maker targets a forgotten market: Black men
A coalition works increase diversity in research and create a digital resource for men with prostate cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 7, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Biotech's surge pushes Bay Area companies — including a Covid drug hopeful — toward collective $1 billion in fresh funds
Three pending Bay Area biotech IPOs and follow-on offerings from four other drug makers could collectively raise more than $1.1 billion, highlighting biotech's latest Wall Street resurgence amid hope for new cancer treatments and drugs and vaccines targeting Covid-19. Annexon Inc., which said last week that it raised $100 million, marked its place for an initial public offering of $100 million filing as Nurix Therapeutics Inc. declared its intentions for a $100 million IPO and Nkarta Inc. detailed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 7, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Blood Pressure Meds May Lower Colon Cancer Risk
A new study suggests that two types of blood pressure drugs might do double-duty, helping blood pressure and keeping colon cancer away, too. (Source: WebMD Health)
Source: WebMD Health - July 7, 2020 Category: Consumer Health News Source Type: news